C. Kis Et Al. , "THE IMPORTANCE OF T315I, T317L, E255K AND Y253H BCR-ABL GENE MUTATIONS IN THE PATIENTS OF CHRONIC MYELOID LEUKEMIA WHO TREATED BY IMATINIB," HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, pp.546, 2010
Kis, C. Et Al. 2010. THE IMPORTANCE OF T315I, T317L, E255K AND Y253H BCR-ABL GENE MUTATIONS IN THE PATIENTS OF CHRONIC MYELOID LEUKEMIA WHO TREATED BY IMATINIB. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95 , 546.
Kis, C., Pehlivan, M., Pehlivan, S., Eser, B., Sever, T., Yilmaz, M., ... Kaynar, L.(2010). THE IMPORTANCE OF T315I, T317L, E255K AND Y253H BCR-ABL GENE MUTATIONS IN THE PATIENTS OF CHRONIC MYELOID LEUKEMIA WHO TREATED BY IMATINIB. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, 546.
Kis, C. Et Al. "THE IMPORTANCE OF T315I, T317L, E255K AND Y253H BCR-ABL GENE MUTATIONS IN THE PATIENTS OF CHRONIC MYELOID LEUKEMIA WHO TREATED BY IMATINIB," HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, 546, 2010
Kis, C. Et Al. "THE IMPORTANCE OF T315I, T317L, E255K AND Y253H BCR-ABL GENE MUTATIONS IN THE PATIENTS OF CHRONIC MYELOID LEUKEMIA WHO TREATED BY IMATINIB." HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, pp.546, 2010
Kis, C. Et Al. (2010) . "THE IMPORTANCE OF T315I, T317L, E255K AND Y253H BCR-ABL GENE MUTATIONS IN THE PATIENTS OF CHRONIC MYELOID LEUKEMIA WHO TREATED BY IMATINIB." HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , vol.95, p.546.
@article{article, author={C. Kis Et Al. }, title={THE IMPORTANCE OF T315I, T317L, E255K AND Y253H BCR-ABL GENE MUTATIONS IN THE PATIENTS OF CHRONIC MYELOID LEUKEMIA WHO TREATED BY IMATINIB}, journal={HAEMATOLOGICA-THE HEMATOLOGY JOURNAL}, year=2010, pages={546} }